Allogene Therapeutics (ALLO) EPS US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EPS, rub | ? | -1.34 | -2.38 | -2.09 | -1.32 | -0.87 | -0.72 | ||
| Changes by years, y/y, % | -36% | +77% | -12% | -37% | -35% | -16.1% | |||
Allogene Therapeutics. EPS, rub
Allogene Therapeutics. EPS, changes, %
Allogene Therapeutics (ALLO) EPS US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EPS, rub | ? | -0.28 | -0.23 | -0.19 | -0.18 | -0.18 | -0.72 | |
| Changes by years, y/y, % | -28% | -33% | -41% | -38% | -36% | |||
| Changes by quarters, q/q, % | -3% | -16% | -20% | -6% | +1% | |||